Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.5577
+0.0482 (9.46%)
Nov 9, 2026, 2:10 PM EST - Market open
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $58.98 million as of November 9, 2026. It is the 29,301st most valuable company in the world and the 4,523rd biggest in the United States. Its market cap has decreased by 49.55% in one year.
Market Cap
58.98M
Enterprise Value
52.63M
1-Year Change
-49.55%
Global Rank
Country Rank
#4,523 United States
Category
ChartMarket Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $58.98M, a decrease of -34.62%. That is a compound annual growth rate of -10.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 58.98M | -30.44% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akebia Therapeutics | 111.43M |
| BGM Group | 110.17M |
| Organogenesis Holdings | 105.55M |
| Cumberland Pharmaceuticals | 78.21M |
| Zhengye Biotechnology Holding | 71.09M |
| Talphera | 54.50M |
| InterCure | 38.91M |
| SCYNEXIS | 34.82M |